Fundamentals

Valuation

Metric	Q3	Q1	Δ in %
EV/EBITDA	1408.09	-217.45	14.42
Graham Fair Price	-1.87	30.40	30.98
PEG	-89.02	0.45	4.08
Price/Book	12.09	1.09	0.97
Price/Cash Flow	-97.55	31.51	1287.86
Prices/Earnings	40.60	10.35	7.36
Price/Sales	-22.22	5.24	6.73
Price/FCF	-97.55	31.51	1287.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-34.23	0.20	0.30
ROA	-12.36	< 0.005	< 0.005
ROE	0.03	0.03	-20.28
ROIC	0.02	0.02	-7.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q1	Δ in %
Debt QOQ	0.19	< 0.005	4955.45
Dividends QOQ	-0.83	< 0.005	-99.75
EBIT QOQ	-0.63	-0.75	-19.82
EPS QOQ	0.02	0.23	1180.77
FCF QOQ	-0.99	0.20	-80.22
Revenue QOQ	< 0.005	0.01	284.46
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	43.88	28.88	-34.18
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.48	0.48	0.74
Quick Ratio	2.97	0.42	-85.73
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q1	Δ in %
Book Value	36.00	39.56	9.90
Cash	85.01	83.88	-1.34
Capex	0.00	-0.20	-100.00
Free Cash Flow	0.03	1.36	4935.57
Revenue	5.18	8.21	58.37
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q1	Δ in %
Current Ratio	2.97	0.12	-95.84
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.18	-73.52	-799.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating